Strategic Family Wealth Counselors L.L.C. purchased a new stake in Globe Life Inc. (NYSE:GL – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 3,920 shares of the company’s stock, valued at approximately $537,000.
Several other large investors have also recently bought and sold shares of the stock. World Investment Advisors raised its holdings in Globe Life by 6.1% in the 4th quarter. World Investment Advisors now owns 3,384 shares of the company’s stock valued at $467,000 after acquiring an additional 195 shares during the period. Hartford Investment Management Co. raised its holdings in Globe Life by 16.0% in the 4th quarter. Hartford Investment Management Co. now owns 6,309 shares of the company’s stock valued at $882,000 after acquiring an additional 871 shares during the period. Swiss Life Asset Management Ltd raised its holdings in Globe Life by 68.2% in the 4th quarter. Swiss Life Asset Management Ltd now owns 6,321 shares of the company’s stock valued at $884,000 after acquiring an additional 2,562 shares during the period. NewEdge Wealth LLC raised its holdings in Globe Life by 52.7% in the 4th quarter. NewEdge Wealth LLC now owns 6,115 shares of the company’s stock valued at $855,000 after acquiring an additional 2,111 shares during the period. Finally, Buck Wealth Strategies LLC raised its holdings in Globe Life by 99.5% in the 4th quarter. Buck Wealth Strategies LLC now owns 9,281 shares of the company’s stock valued at $1,298,000 after acquiring an additional 4,630 shares during the period. 81.61% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
Several research analysts have weighed in on GL shares. Texas Capital raised shares of Globe Life to a “strong-buy” rating in a report on Wednesday, March 18th. Evercore set a $157.00 price target on shares of Globe Life in a report on Wednesday, February 18th. Wells Fargo & Company increased their price target on shares of Globe Life from $171.00 to $172.00 and gave the company an “overweight” rating in a report on Friday, April 10th. JPMorgan Chase & Co. increased their price target on shares of Globe Life from $180.00 to $181.00 and gave the company an “overweight” rating in a report on Thursday, February 5th. Finally, Truist Financial increased their price target on shares of Globe Life from $180.00 to $185.00 and gave the company a “buy” rating in a report on Friday, April 24th. Two investment analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Buy” and an average price target of $172.67.
Globe Life Trading Down 1.3%
Shares of GL stock opened at $152.87 on Thursday. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.38. The stock has a market cap of $11.87 billion, a P/E ratio of 10.57 and a beta of 0.50. The stock has a 50 day simple moving average of $145.57 and a 200 day simple moving average of $140.89. Globe Life Inc. has a 1 year low of $116.73 and a 1 year high of $156.69.
Globe Life (NYSE:GL – Get Free Report) last issued its quarterly earnings results on Wednesday, April 22nd. The company reported $3.43 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.46 by ($0.03). The company had revenue of $1.56 billion during the quarter, compared to the consensus estimate of $1.56 billion. Globe Life had a net margin of 19.38% and a return on equity of 20.94%. The company’s quarterly revenue was up 5.3% on a year-over-year basis. During the same quarter last year, the firm posted $3.07 earnings per share. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. On average, research analysts predict that Globe Life Inc. will post 15.56 earnings per share for the current fiscal year.
Globe Life Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Monday, July 6th will be paid a $0.33 dividend. This represents a $1.32 annualized dividend and a dividend yield of 0.9%. The ex-dividend date is Monday, July 6th. Globe Life’s payout ratio is 9.13%.
Insiders Place Their Bets
In related news, EVP Robert Edward Hensley sold 712 shares of Globe Life stock in a transaction that occurred on Wednesday, February 25th. The shares were sold at an average price of $142.59, for a total value of $101,524.08. Following the transaction, the executive vice president directly owned 8,580 shares of the company’s stock, valued at $1,223,422.20. This trade represents a 7.66% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO James Matthew Darden sold 4,663 shares of Globe Life stock in a transaction that occurred on Tuesday, April 28th. The shares were sold at an average price of $153.88, for a total transaction of $717,542.44. Following the completion of the transaction, the chief executive officer directly owned 58,451 shares in the company, valued at $8,994,439.88. This trade represents a 7.39% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 107,147 shares of company stock valued at $16,086,366 in the last quarter. Company insiders own 2.11% of the company’s stock.
Globe Life Profile
Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.
The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.
Recommended Stories
- Five stocks we like better than Globe Life
- D-Wave Earnings Looked Weak, But Investors May Be Missing This
- Nebius Upside Expands as AI Feedback Loop Intensifies
- Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell
- Plug Power Flips The Switch On Profitability
Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.
